Nykode Therapeutics ASA — Director's Dealing 2022

Dec 18, 2022

1	Details of the person discharging managerial responsibilities
a)	Name	Agnete Brunsvik Fredriksen
b)	Position	CBO
2	Reason for notification
a)	Initial notification/ Amendment	Initial
3	Details of issuer
a)	Name	Nykode Therapeutics ASA
b)	LEI	254900UKQHWYZJD22017
4	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Warrants in Nykode Therapeutics ASA (ISIN: NO0010714785)
b)	Nature of the transaction	Exercise of warrants
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 2.5	1,215,000
		NOK 2.5	1,088,000
		NOK 2.5	207,900
		NOK 0.525	164,000
		NOK 0.5	276,000
		NOK 0.33915	884,000
d)	Aggregated information	Price	NOK 1.7735
	-Average price,	Volume	3,834,900
	aggregated volume and total amount	Total amount	NOK 6,801,158.60
e)	Date of the transaction	18.12.2022
f)	Place of the transaction	Outside of trading venue

1	Details of the closely associated enterprise
a)	Name	RASMUSSENGRUPPEN AS
2	Details of the person discharging managerial responsibilities
a)	Name	Trygve Lauvdal
b)	Position	Observer to the Board
3	Reason for notification
b)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Nykode Therapeutics ASA
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Nykode Therapeutics ASA (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 31.60	2,000,000
d)	Aggregated information	Price	NOK 31.60
	-Average price,	Volume	2,000,000
	aggregated volume and total amount	Total amount	NOK 63,200,000
e)	Date of the transaction	18.12.2022
f)	Place of the transaction	Outside of trading venue

1	Details of the closely associated enterprise
a)	Name	Viginti AS
2	Details of the person discharging managerial responsibilities
a)	Name	Agnete Brunsvik Fredriksen
b)	Position	CBO
3	Reason for notification
b)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Nykode Therapeutics ASA
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Nykode Therapeutics ASA (ISIN: NO0010714785)
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 31.60	1,834,900
d)	Aggregated information	Price	NOK 31.60
	-Average price,	Volume	1,834,900
	aggregated volume and total amount	Total amount	NOK 57,982,840
e)	Date of the transaction	18.12.2022
f)	Place of the transaction	Outside of trading venue

1	Details of the person discharging managerial responsibilities
a)	Name	Agnete Brunsvik Fredriksen
b)	Position	CBO
2	Reason for notification
a)	Initial notification/	Initial
	Amendment
3	Details of issuer
a)	Name	Nykode Therapeutics ASA
b)	LEI	254900UKQHWYZJD22017
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Shares in Nykode Therapeutics ASA (ISIN: NO0010714785)
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 31.60	3,834,900
d)	Aggregated information	Price	NOK 31.60
	-Average price,	Volume	3,834,900
	aggregated volume and total amount	Total amount	NOK 121,182,840
e)	Date of the transaction	18.12.2022
f)	Place of the transaction	Outside of trading venue